13FPulse
中
AT

ATYR ATYR PHARMA INC

2026Q1 · CUSIP 002120202 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
110
Δ holders QoQ
+27
Breadth percentile
Top 11%
Whale holders
63
Δ whales
+17
Inst. holding value
$44M
New positions
37
Closed positions
10
Price momentum (1Q)
—
Put / Call
5/5

Breadth history (34 quarters)

2019Q3: holders=19 2019Q4: holders=18 2020Q1: holders=24 2020Q2: holders=25 2020Q3: holders=24 2020Q4: holders=23 2021Q1: holders=24 2021Q2: holders=29 2021Q3: holders=42 2021Q4: holders=48 2022Q1: holders=42 2022Q2: holders=37 2022Q3: holders=34 2022Q4: holders=37 2023Q1: holders=39 2023Q2: holders=42 2023Q3: holders=42 2023Q4: holders=48 2024Q1: holders=57 2024Q2: holders=48 2024Q3: holders=56 2024Q4: holders=78 2025Q1: holders=88 2025Q2: holders=111 2025Q3: holders=104 2025Q4: holders=83 2026Q1: holders=110 -27 -13.5 +0 +13.5 +27 1667117 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 11% — —
2025Q2 Top 13% -84.7% -79.8%
2021Q3 Top 14% -39.0% -64.8%

Options Sentiment

Put holders
5
QoQ: 0
Call holders
5
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.74
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-120.9%
Debt ratio
27.3%
FCF (TTM)
-$59M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.44 2022-09-30: EPS -0.46 2022-12-31: EPS -0.26 2023-03-31: EPS -0.29 2023-06-30: EPS -0.22 2023-09-30: EPS -0.20 2023-12-31: EPS -0.23 2024-03-31: EPS -0.23 2024-06-30: EPS -0.23 2024-09-30: EPS -0.23 2024-12-31: EPS -0.17 2025-03-31: EPS -0.17 2025-06-30: EPS -0.22 2025-09-30: EPS -0.26 2025-12-31: EPS -0.15 2026-03-31: EPS -0.11 -0.51 -0.25 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.